Jul 18 2023 8 mins 1
Pharmeasy had to choose between selling its recent acquisition, Thyrocare, or stifling its investors that have been with it for the last 8 years. It chose the latter.
Get full access to Boring Money at boringmoney.in/subscribe
Pharmeasy prefers selling itself over selling Thyrocare
1.0x
00:00
00:00
Get full access to Boring Money at boringmoney.in/subscribe
